Epigenetic clocks reveal a rejuvenation event during embryogenesis followed by aging.
Level 5 - mechanism / opinion, no new human data
Preclinical and computational tracking study in embryonic and stem cell models without clinical human trial data.
PubMed 34172448 · doi:10.1126/sciadv.abg6082
What was done
Researchers developed a multi-tissue epigenetic clock and applied it, along with existing aging clocks, to measure changes in biological age across mouse and human prenatal development and in extensively passaged pluripotent stem cells.
What was found
The analysis detected a significant decrease in biological age during early embryogenesis (rejuvenation) followed by an increase in later developmental stages. Pluripotent stem cells showed no evidence of aging despite extensive passaging, indicating conserved epigenetic age dynamics across species. The abstract reports no specific numerical measurements, clock values, or statistical metrics.
Why it matters
The study proposes a developmental ground zero where organismal biological age resets early in embryonic life, offering a mechanism for how lineage aging is cleared across generations.
Limits
The abstract provides no sample sizes, effect sizes, or quantitative confidence bounds. The conclusions depend entirely on the calibration and assumptions of epigenetic clock algorithms in embryonic and stem cell tissue rather than direct functional measures of aging.
Cited by
- supports Early embryonic development involves an epigenetic reset that resets the cell's biological age back to zero.